dRx Capital Novartis Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 43

  • Portfolio
  • 13

  • Exits
  • 14

Exits

dRx Capital Novartis General Information

Company Description

Founded in 2015, dRx Capital Novartis is a venture capital firm based in Basel, Switzerland. The firm prefers to invest in healthcare, artificial intelligence and machine learning, big data, research and development optimization, patient care, and the pharma supply chain and commercialization sectors.

Business Details

Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Novartis Campus
  • 4056 Basel
  • Switzerland

dRx Capital Novartis Investments (43)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Yseop 05-Dec-2023 PE Growth/Expansion Business/Productivity Software Generating Revenue
Octave Bioscience 26-Jul-2023 Laboratory Services (Healthcare) Generating Revenue
RxLightning 24-May-2023 Enterprise Systems (Healthcare) Generating Revenue
Holmusk 06-Jan-2023 Enterprise Systems (Healthcare) Generating Revenue
H1 Insights 09-Jun-2022 Other Healthcare Services Generating Revenue
Peptone 09-Jun-2022 Discovery Tools (Healthcare) Pre-Clinical Trials
Koneksa 07-Feb-2022 Other Healthcare Technology Systems Clinical Trials - General
NuvoAir Medical 19-Jan-2022 Clinics/Outpatient Services Generating Revenue
Pear Therapeutics 03-Dec-2021 PIPE Other Healthcare Technology Systems Out of Business
Cala Health 16-Nov-2021 Later Stage VC Therapeutic Devices Generating Revenue
You’re viewing 10 of 43 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

dRx Capital Novartis Exits (14)

Company Name Exit Date Exit Type Exit Size
Freenome 20-Jul-2026 Reverse Merger
YourBio Health 01-Jan-2026
Aktana 31-Oct-2025
Xealth 08-Jul-2025
Omada 06-Jun-2025
RxLightning 01-Jun-2025
Science 37 Holdings 11-Mar-2024
Tact.ai 01-Nov-2023
Aspen RxHealth 01-Jan-2023 Merger/Acquisition
Pear Therapeutics 03-Dec-2021 Reverse Merger
You’re viewing 10 of 14 exits. Get the full list »

dRx Capital Novartis Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

dRx Capital Novartis FAQs

  • What is dRx Capital Novartis?

    Founded in 2015, dRx Capital Novartis is a venture capital firm based in Basel, Switzerland.

  • When was dRx Capital Novartis founded?

    dRx Capital Novartis was founded in 2015.

  • Where is dRx Capital Novartis headquartered?

    dRx Capital Novartis is headquartered in Basel, Switzerland.

  • What is dRx Capital Novartis's total asset value?

    dRx Capital Novartis has around in total assets under management.

  • How many investments has dRx Capital Novartis made?

    dRx Capital Novartis has made 43 investments.

  • What has dRx Capital Novartis invested in?

    dRx Capital Novartis has made numerous investments in companies like Yseop, Octave Bioscience, and RxLightning within the Business/Productivity Software, Laboratory Services (Healthcare), and Enterprise Systems (Healthcare) industries.

  • What has dRx Capital Novartis invested in recently?

    dRx Capital Novartis's latest investment was on 05-Dec-2023 in Yseop, a company within the Business/Productivity Software industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process